Citalopram Oral Solution — Class III drug recall D-0015-2021
Terminated recall by PAI Holdings, LLC. dba Pharmaceutical Associates Inc, reported 2020-10-14, distributed nationwide. Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stabil
| Recall number | D-0015-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PAI Holdings, LLC. dba Pharmaceutical Associates Inc, Greenville, SC, United States |
| Recall initiated | 2020-09-09 |
| Classified | 2020-10-05 |
| Reported by FDA | 2020-10-14 |
| Terminated | 2022-02-22 |
| Distributed | Nationwide (US) |
| Quantity | 13,480 cups |
| Reason classes | specification failure |
| NDC | 00121-1696-40 |
| Lot numbers | BD82, BD83, C16D, C1EE, C563, C574 |
| Expiration dates | 2020-11, 2021-02, 2021-04, 2021-11 |
Product
Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40
Reason for recall
Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0015-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.